The Omicron Variant of Concern: Diversification and Convergent Evolution in Spike Protein, and Escape From Anti-spike Monoclonal Antibodies

Elsevier

Available online 3 October 2022, 100882

Drug Resistance UpdatesAbstract

WHO-defined SARS-CoV-2 variants of concern (VOC) drive therapeutics and vaccine development. The Omicron VOC is dominating the arena since November 2021, but the number of its sublineages is growing in complexity. Omicron represent a galaxy with a myriad of stars that suddenly rise and expand before collapsing into apparent extinction when a more fit sublineage appears. This has already happened with BA.1, BA.2, and BA.4/5 and is happening with BA.2.75. We review here the current PANGO phylogeny, focusing on sublineages with Spike mutations, and show how common convergent evolution has occurred in these sublineages. We finally summarize how Omicron evolution has progressively defeated the anti-Spike monoclonal antibodies authorized so far, leaving clinicians to again fall back on COVID19 convalescent plasma from vaccinated donors as the only antibody-based therapy available.

AbbreviationsLUM

lineage under monitoring

Keywords

SARS-CoV-2

Spike

variant of concern

VOC

Omicron

B.1.1.529

BA.1

BA.2

BA.2.12.1

BA.4

BA.5

BA.2.75

BA.4.6

View Abstract

© 2022 Elsevier Ltd. All rights reserved.

留言 (0)

沒有登入
gif